Cover Image

An Emerging Role of Glucagon-Like Peptide-1 in Preventing Advanced-Glycation-End-Product-Mediated Damages in Diabetes

Glucagon-like peptide-1 (GLP-1) is a gut hormone produced in the intestinal epithelial endocrine L cells by differential processing of the proglucagon gene. Released in response to the nutrient ingestion, GLP-1 plays an important role in maintaining glucose homeostasis. GLP-1 has been shown to regul...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alessandra Puddu (Author), François Mach (Author), Alessio Nencioni (Author), Giorgio Luciano Viviani (Author), Fabrizio Montecucco (Author)
Format:	Book
Published:	Hindawi Limited, 2013-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Glucagon-Like Peptide-1 Triggers Protective Pathways in Pancreatic Beta-Cells Exposed to Glycated Serum
by: Alessandra Puddu, et al.
Published: (2013)

Advanced Glycation End Products Play Adverse Proinflammatory Activities in Osteoporosis
by: Roberta Sanguineti, et al.
Published: (2014)

Glucagon-Like Peptide-1 Secreting Cell Function as well as Production of Inflammatory Reactive Oxygen Species Is Differently Regulated by Glycated Serum and High Levels of Glucose
by: Alessandra Puddu, et al.
Published: (2014)

Retinal Pigment Epithelial Cells Express a Functional Receptor for Glucagon-Like Peptide-1 (GLP-1)
by: Alessandra Puddu, et al.
Published: (2013)

Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells
by: Jui-Ting Chang, et al.
Published: (2017)

Update on the Protective Molecular Pathways Improving Pancreatic Beta-Cell Dysfunction
by: Alessandra Puddu, et al.
Published: (2013)

Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes
by: Alessandra Puddu, et al.
Published: (2014)

Role of Mitogen-Activated Protein Kinase Pathways in Multifactorial Adverse Cardiac Remodeling Associated with Metabolic Syndrome
by: Mohamed Asrih, et al.
Published: (2013)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
by: Seungah Lee, et al.
Published: (2017)

Glucagon-like peptide 1 (GLP-1)
by: T.D. Müller, et al.
Published: (2019)

Physiology and pharmacology of glucagon-like peptide-1 receptor
by: D. V. Kurkin, et al.
Published: (2024)

Investigating the Glucagon Receptor and Glucagon-Like Peptide 1 Receptor Activity of Oxyntomodulin-Like Analogues in Male Wistar Rats
by: Samantha L. Price, MRes, et al.
Published: (2015)

Pharmacogenetics of Glucagon-like-peptide-1 receptor in diabetes management
by: Mariya Kalinkova, et al.
Published: (2023)

Effects of exercise on glucagon-like peptide-1 (GLP-1)
by: Shin-ya Ueda, et al.
Published: (2013)

Glucagon-like peptide-1 receptor agonists rescued diabetic vascular endothelial damage through suppression of aberrant STING signaling
by: Xuemin He, et al.
Published: (2024)

Glucagon-like peptide-1 (GLP-1) agonists in the treatment of obesity
by: Magdalena Mazurek, et al.
Published: (2023)

Evidence for Activation of Toll-Like Receptor and Receptor for Advanced Glycation End Products in Preterm Birth
by: Taketoshi Noguchi, et al.
Published: (2010)

Insulin Resistance: A Proinflammatory State Mediated by Lipid-Induced Signaling Dysfunction and Involved in Atherosclerotic Plaque Instability
by: Fabrizio Montecucco, et al.
Published: (2008)

Possibilities of using analogues of glucagon-like peptide-1 in various disease entities
by: Weronika Bielka, et al.
Published: (2021)

Pharmacoeconomic characteristics of agonists of receptors for glucagon-like peptide-1 and medicines on their base
by: I. N. Dyakov, et al.
Published: (2021)

Microbially produced glucagon-like peptide 1 improves glucose tolerance in mice
by: Tulika Arora, et al.
Published: (2016)

Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
by: Laurie L. Baggio, et al.
Published: (2021)

Glucagon-like peptide-1 receptor agonists and derivatives in the treatment of obesity - review
by: Michal Rabenda, et al.
Published: (2024)

Glyoxal-Lysine Dimer, an Advanced Glycation End Product, Induces Oxidative Damage and Inflammatory Response by Interacting with RAGE
by: Hee-Weon Lee, et al.
Published: (2021)

Co-storage and release of insulin-like peptide-5, glucagon-like peptide-1 and peptideYY from murine and human colonic enteroendocrine cells
by: Lawrence J. Billing, et al.
Published: (2018)

Neural regulation of hindlimb muscle contraction-induced glucagon-like peptide-1 and peptide YY secretion in rats
by: Shin-ya Ueda, et al.
Published: (2015)

Effect of Glucagon-like peptide-1 receptor agonists on dyslipidemia in type 2 diabetes
by: Elizabeth A. Cristiano, et al.
Published: (2020)

Impact of Glucagon-like Peptide-1 Receptor Agonists on Intestinal Epithelial Cell Barrier
by: Takizawa Y., et al.
Published: (2024)

Enteroendocrine-derived glucagon-like peptide-2 controls intestinal amino acid transport
by: Jennifer Lee, et al.
Published: (2017)

Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain
by: Simon C. Cork, et al.
Published: (2015)

The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury
by: Anja Harej Hrkać, et al.
Published: (2024)

Amelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy
by: Yeonhee Hong, et al.
Published: (2019)

Use of Glucagon-like peptide 2 (GLP-2) analogs in inflammatory bowel disease
by: Dobromiła Osuch, et al.
Published: (2024)

Relationship of Glucagon-like Peptide 1 and Peptide YY with Catch-up Growth in Children Born Small for Gestational Age
by: Li Wang, et al.
Published: (2024)

Glucagon-Like Peptide-1 Analog Exendin-4 Ameliorates Cocaine-Mediated Behavior by Inhibiting Toll-Like Receptor 4 Signaling in Mice
by: Changliang Zhu, et al.
Published: (2021)

Role of Advanced Glycation End Products in the Progression of Diabetes Mellitus
by: Hengli Guo, et al.
Published: (2017)

Relationship between Advanced Glycation End Products and Steroidogenesis in PCOS
by: Deepika Garg, et al.
Published: (2016)

Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus
by: Olusola F. Onoviran, et al.
Published: (2019)

Glucagon-like peptide-1 receptor agonists for treatment of diabetes and obesity: advantage of oral delivery
by: R. R. C. New, et al.
Published: (2024)

Glucagon-Like Peptide-1 (GLP-1) during Ramadan: Narrative Review of the Published Literature
by: Khalid Mohammed Alayed
Published: (2023)